On Monday, Structure Therapeutics Inc ADR (NASDAQ: GPCR) opened lower -5.12% from the last session, before settling in for the closing price of $21.68. Price fluctuations for GPCR have ranged from $13.22 to $52.14 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted -9.02% at the time writing. With a float of $54.69 million, this company’s outstanding shares have now reached $57.54 million.
Let’s determine the extent of company efficiency that accounts for 163 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Structure Therapeutics Inc ADR (GPCR) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Structure Therapeutics Inc ADR is 4.94%, while institutional ownership is 93.69%.
Structure Therapeutics Inc ADR (GPCR) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.4 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -9.02% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -29.12% during the next five years compared to -51.75% drop over the previous five years of trading.
Structure Therapeutics Inc ADR (NASDAQ: GPCR) Trading Performance Indicators
Check out the current performance indicators for Structure Therapeutics Inc ADR (GPCR). In the past quarter, the stock posted a quick ratio of 23.29.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.58, a number that is poised to hit -0.28 in the next quarter and is forecasted to reach -1.49 in one year’s time.
Technical Analysis of Structure Therapeutics Inc ADR (GPCR)
Looking closely at Structure Therapeutics Inc ADR (NASDAQ: GPCR), its last 5-days average volume was 0.88 million, which is a drop from its year-to-date volume of 0.9 million. As of the previous 9 days, the stock’s Stochastic %D was 32.28%. Additionally, its Average True Range was 1.48.
During the past 100 days, Structure Therapeutics Inc ADR’s (GPCR) raw stochastic average was set at 39.73%, which indicates a significant increase from 7.94% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 52.86% in the past 14 days, which was lower than the 83.46% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $22.41, while its 200-day Moving Average is $29.10. However, in the short run, Structure Therapeutics Inc ADR’s stock first resistance to watch stands at $21.51. Second resistance stands at $22.44. The third major resistance level sits at $22.92. If the price goes on to break the first support level at $20.10, it is likely to go to the next support level at $19.62. Now, if the price goes above the second support level, the third support stands at $18.69.
Structure Therapeutics Inc ADR (NASDAQ: GPCR) Key Stats
There are currently 57,343K shares outstanding in the company with a market cap of 1.18 billion. Presently, the company’s annual sales total 0 K according to its annual income of -122,530 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -46,830 K.
